Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
基本信息
- 批准号:10084263
- 负责人:
- 金额:$ 46.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-07 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsActive SitesAirAnabolismAntibioticsBacteriaChelating AgentsCleaved cellComplementCopperCountryDefectDevelopmentDiffuseDiseaseElementsEnvironmentGene Expression ProfilingGenetic EpistasisGenetic TranscriptionGrowthHomeostasisHypoxiaInfectionLinkMediatingMediator of activation proteinMembraneMetalloproteasesMetalsMolecularMorbidity - disease rateMusMycobacterium tuberculosisNOS2A geneNitric OxideOperonOxidative StressPathogenesisPathway interactionsPeptide HydrolasesPeptidesPhenotypePhosphorylationPhosphotransferasesProductionProtein-Serine-Threonine KinasesProteolysisRIPK1 geneRNARNA BindingResistanceRoleSigma FactorSignal TransductionSignaling MoleculeStressStructureSystemTestingTuberculosisVaccinesVirulenceattenuationbasebiological adaptation to stresscofactorgene repressiongenome sequencinginsightmortalitymouse modelmutantnovelpathogenpeptide synthaseprogramsresponsesensorwhole genome
项目摘要
Project Summary
The molecular basis of M. tuberculosis virulence is still incompletely understood. Within the host, M.
tuberculosis must respond to, and resist, a plethora of stresses. Recent studies using genetically defined
bacterial mutants have identified several signal transduction systems as critical to sense and respond to the
host environment, including two component systems, transmembrane serine threonine kinases, and proteolytic
systems. Rip1 is an intramembrane metalloprotease (S2P class) required for M. tuberculosis virulence in the
mouse. Intramembrane proteases are membrane bound proteases with active sites in the membrane which
cleave transmembrane substrates. Rip1 has four known substrates, the membrane spanning anti-sigma factors
for SigK,L,M and D. However, the severe virulence defect of M. tuberculosis Drip1 is not phenocopied by an M.
tuberculosis DsigKLM triple mutant or DsigD, raising the likelihood that additional downstream pathways
controlled by Rip1 are the critical mediators of virulence. We have determined that Rip1 is required for
resistance to several stresses relevant to pathogenesis, including copper, nitric oxide, and hypoxia. However,
these phenotypes are independent of the four Rip1 controlled sigma factor pathways. Genetic epistasis analysis
indicates that the copper and NO resistance pathway controlled by the Rip1 protease is independent of known
copper efflux and Cu/NO induced transcriptional systems, indicating a novel mechanism of metal/NO
resistance. Surprisingly, loss of anti-SigD (but not SigD, see above), a Rip1 substrate, causes severe copper
sensitivity, suggesting an independent signaling role for this anti-Sigma, independent of its cognate sigma. We
have isolated spontaneous mutants in the Drip1 background that suppress the Drip1 copper sensitivity
phenotype and, by counterscreening these mutants against other stresses, whole genome sequencing, and
complementation, have identified the PdtaS/PdtaR sensor kinase/response regulator pair as mediator of the
Rip1 dependent copper and NO resistance. Transcriptional profiling reveals that the Rip1/PdtaS/PdtaR system
controls, through transcriptional repression, stress induced expression of an operon encoding a nonribosomal
peptide synthase recently shown to direct synthesis of a copper chelating peptide (a chalkophore), suggesting
a plausible direct link to copper homeostasis. We also find that the virulence defect of the Drip1 strain is
substantially reversed in NOS2 deficient mice, confirming that sensitivity to nitric oxide is the a contributor to
the attenuation of the Drip1 strain. Based on these novel findings, we propose an experimental program to
dissect the molecular mechanisms by which this newly discovered M. tuberculosis Rip1/PdtaS/PdtaR signaling
cascade controls a stress response pathway that integrates cellular response to copper, nitric oxide, and
hypoxia, the contribution of chalkophore biosynthesis to this pathway, and the role of this pathway in M.
tuberculosis virulence. Characterization of this pathway through the following specific aims will yield significant
insight into M. tuberculosis host-pathogen interactions.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Stephen Glickman其他文献
Michael Stephen Glickman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Stephen Glickman', 18)}}的其他基金
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
- 批准号:
10547809 - 财政年份:2019
- 资助金额:
$ 46.33万 - 项目类别:
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
- 批准号:
10338102 - 财政年份:2019
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
10226974 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
10453636 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
9979823 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究小组:持续性和潜伏期
- 批准号:
8691646 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究单位:持续性和潜伏期
- 批准号:
9753887 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究单位:持续性和潜伏期
- 批准号:
9081457 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Epidemiology of SARS-CoV-2 in Low-income Countries.
低收入国家 SARS-CoV-2 的流行病学。
- 批准号:
10188735 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 46.33万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




